A first-in-man phase I trial of a new monoclonal antibody labelled with yttrium 90 for radioimmunotherapy of relapsed or refractory non resectable synovial-sarcomas

✍ Scribed by Badel, J.; Desuzinges, C.; Rey, S.; Baconnier, S.; Perol, D.; Garin, G.; Cassier, P.; Blay, J.; Nakamura, Y.; Fukukawa, C.; Mognetti, T.

• Book ID: 122742553
• Publisher: Elsevier
• Year: 2013
• Tongue: English
• Weight: 113 KB
• Volume: 29
• Category: Article
• ISSN: 1120-1797
• DOI: 10.1016/j.ejmp.2013.08.085